Yongwook Choi

Yongwook Choi

Auto-generated profile, based on publicly available information

Yongwook Choi

Translational Genomics Research Institute, Phoenix, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in mSphere
Verified
Journal Article
Open access
PDF file
ACAgnes P. Chan
Agnes P. Chan
YCYongwook Choi
Yongwook Choi
NSNicholas Schork
Nicholas Schork
The CoV disease 2019 (COVID-19) infectious disease outbreak is having a dramatic global effect on public health and the economy. As of October 2020, SARS-CoV-2 has been detected in over 189 countries, has infected over 40 million people, and is responsible for more than 1 million deaths.

29 March 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
JEJosh L. Espinoza
Josh L. Espinoza
CDChris L. Dupont
Chris L. Dupont
AOAubrie Elise O'Rourke
Aubrie Elise O'Rourke
SBSinem Beyhan
Sinem Beyhan
PMPavel Morales
Pavel Morales
KNKaren E. Nelson
Karen E. Nelson
To better combat the expansion of antibiotic resistance in pathogens, new compounds, particularly those with novel mechanisms-of-action [MOA], represent a major research priority in biomedical science. However, rediscovery of known antibiotics demonstrates a need for approaches that accurately identify potential novelty with higher throughput and reduced labor. Here we describe an explainable artificial intelligence classification methodology that emphasizes prediction performance and human interpretability by using a Hierarchical Ensemble of Classifiers model optimized with a novel feature selection algorithm called Clairvoyance; collectively referred to as a CoHEC model. We evaluated our methods using whole transcriptome responses from Escherichia coli challenged with 41 known antibiotics and 9 crude extracts while depositing 122 transcriptomes unique to this study. Our CoHEC model can properly predict the primary MOA of previously unobserved compounds in both purified forms and crude extracts at an accuracy above 99%, while also correctly identifying darobactin, a newly discovered antibiotic, as having a novel MOA. In addition, we deploy our methods on a recent E. coli transcriptomics dataset from a different strain and a Mycobacterium smegmatis metabolomics timeseries dataset showcasing exceptionally high performance; improving upon the performance metrics of the original publications. We not only provide insight into the biological interpretation of our model but also that the concept of MOA is a non-discrete heuristic with diverse effects for different compounds within the same MOA, suggesting substantial antibiotic diversity awaiting discovery within existing MOA.

28 August 2009 in IEEE Journal on Selected Areas in Communications
Verified
Journal Article
Closed access
YCYongwook Choi
Yongwook Choi
MKMaleq Khan
Maleq Khan
VKVikas Kumar
Vikas Kumar
GPGopal Pandurangan
Gopal Pandurangan
Traditionally, the performance of distributed algorithms has been measured in terms of time and message complexity.Message complexity concerns the number of messages transmitted over all the edges during the course of the algorithm. However, in energy-constrained ad hoc wireless networks (e.g., sensor networks), energy is a critical factor in measuring the efficiency of a distributed algorithm. Transmitting a message between two nodes has an associated cost (energy) and moreover this cost can depend on the two nodes (e.g., the distance between them among other things). Thus in addition to the time and message complexity, it is important to consider energy complexity that accounts for the total energy associated with the messages exchanged among the nodes in a distributed algorithm. This paper addresses the minimum spanning tree (MST) problem, a fundamental problem in distributed computing and communication networks. We study energy-efficient distributed algorithms for the Euclidean MST problem assuming random distribution of nodes. We show a non-trivial lower bound of Omega(log n) on the energy complexity of any distributed MST algorithm. We then give an energy-optimal distributed algorithm that constructs an optimal MST with energy complexity O(log n) on average and O(log n log log n) with high probability. This is an improvement over the previous best known bound on the average energy complexity of Omega(log2 n). Our energy-optimal algorithm exploits a novel property of the giant component of sparse random geometric graphs. All of the above results assume that nodes do not know their geometric coordinates. If the nodes know their own coordinates, then we give an algorithm with O(1) energy complexity (which is the best possible) that gives an O(1) approximation to the MST.

6 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAgnes. P. Chan
Agnes. P. Chan
YCYongwook Choi
Yongwook Choi
NSNicholas Schork
Nicholas Schork
To identify features in the genome of the SARS-CoV-2 pathogen responsible for the COVID-19 pandemic that may contribute to its viral replication, host pathogenicity, and vulnerabilities, we investigated how and to what extent the SARS-CoV-2 genome sequence differs from other well-characterized human and animal coronavirus genomes. Our analyses suggest the presence of unique sequence signatures in the 3’-untranslated region (UTR) of betacoronavirus lineage B, which phylogenetically encompasses SARS-CoV-2, SARS-CoV, as well as multiple groups of bat and animal coronaviruses. In addition, we identified genome-wide patterns of variation across different SARS-CoV-2 strains that likely reflect the effects of selection. Finally, we provide evidence for a possible host microRNA-mediated interaction between the 3’-UTR and human microRNA hsa-miR-1307-3p based on predicted, yet extensive, complementary base-pairings and similar interactions involving the Influenza A H1N1 virus. This interaction also suggests a possible survival mechanism, whereby a mutation in the SARS-CoV-2 3’-UTR leads to a weakened host immune response. The potential roles of host microRNAs in SARS-CoV-2 replication and infection, and the exploitation of conserved features in the 3’-UTR as therapeutic targets warrant further investigation.

2 December 2024 in Scientific Data
Verified
Journal Article
Open access
PDF file
PRPanga J. Reddy
Panga J. Reddy
ZSZhi Sun
Zhi Sun
HWHelisa H. Wippel
Helisa H. Wippel
DBDavid H. Baxter
David H. Baxter
KSKristian Swearingen
Kristian Swearingen
RMRobert Moritz
Robert Moritz
Lyme disease is caused by an infection with the spirochete Borrelia burgdorferi, and is the most common vector-borne disease in North America. B. burgdorferi isolates harbor extensive genomic and proteomic variability and further comparison of isolates is key to understanding the infectivity of the spirochetes and biological impacts of identified sequence variants. Here, we applied both transcriptome analysis and mass spectrometry-based proteomics to assemble peptide datasets of B. burgdorferi laboratory isolates B31, MM1, and the infective isolate B31-5A4, to provide a publicly available Borrelia PeptideAtlas. Included are total proteome, secretome, and membrane proteome identifications of the individual isolates. Proteomic data collected from 35 different experiment datasets, totaling 386 mass spectrometry runs, have identified 81,967 distinct peptides, which map to 1,113 proteins. The Borrelia PeptideAtlas covers 86% of the total B31 proteome of 1,291 protein sequences. The Borrelia PeptideAtlas is an extensible comprehensive peptide repository with proteomic information from B. burgdorferi isolates useful for Lyme disease research.

16 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PRPanga Jaipal. Reddy
Panga Jaipal. Reddy
ZSZhi Sun
Zhi Sun
HWHelisa H. Wippel
Helisa H. Wippel
DBDavid H Baxter
David H Baxter
KSKristian Swearingen
Kristian Swearingen
RMRobert Moritz
Robert Moritz
Lyme disease, caused by an infection with the spirochete Borrelia burgdorferi , is the most common vector-borne disease in North America. B. burgdorferi strains harbor extensive genomic and proteomic variability and further comparison is key to understanding the spirochetes infectivity and biological impacts of identified sequence variants. To achieve this goal, both transcript and mass spectrometry (MS)-based proteomics was applied to assemble peptide datasets of laboratory strains B31, MM1, B31-ML23, infective isolates B31-5A4, B31-A3, and 297, and other public datasets, to provide a publicly available Borrelia PeptideAtlas ( http://www.peptideatlas.org/builds/borrelia/ ). Included is information on total proteome, secretome, and membrane proteome of these B. burgdorferi strains. Proteomic data collected from 35 different experiment datasets, with a total of 855 mass spectrometry runs, identified 76,936 distinct peptides at a 0.1% peptide false-discovery-rate, which map to 1,221 canonical proteins (924 core canonical and 297 noncore canonical) and covers 86% of the total base B31 proteome. The diverse proteomic information from multiple isolates with credible data presented by the Borrelia PeptideAtlas can be useful to pinpoint potential protein targets which are common to infective isolates and may be key in the infection process.